Back
Prelude Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
63
PRLD
Prelude Therapeutics, Inc.
Last Price:
$2.44
Seasonality Move:
-0.12%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PRLD is experiencing buying pressure, which is a positive indicator for future bullish movement.
Prelude Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.14 | Buy |
| 20-day SMA: | 1.81 | Buy |
| 50-day SMA: | 1.68 | Buy |
| 200-day SMA: | 1.13 | Buy |
| 8-day EMA: | 1.85 | Buy |
| 20-day EMA: | 1.11 | Buy |
| 50-day EMA: | 0.53 | Buy |
| 200-day EMA: | 0.15 | Buy |
Prelude Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.62 | Buy |
| Relative Strength Index (14 RSI): | 68.47 | Buy |
| Chaikin Money Flow: | 207812 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.46 - 2.06) | Buy |
| Bollinger Bands (100): | (1.01 - 1.85) | Buy |
Prelude Therapeutics, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Prelude Therapeutics, Inc. Stock
Is Prelude Therapeutics, Inc. Stock a Buy?
-
Prelude Therapeutics, Inc. share price is 2.45 while PRLD 8-day simple moving average is 2.14, which is a Buy signal.
-
The stock price of PRLD is 2.45 while Prelude Therapeutics, Inc. 20-day SMA is 1.81, which makes it a Buy.
-
Prelude Therapeutics, Inc. 50-day simple moving average is 1.68 while PRLD share price is 2.45, making it a Buy technically.
-
PRLD stock price is 2.45 and Prelude Therapeutics, Inc. 200-day simple moving average is 1.13, creating a Buy signal.
PRLD Technical Analysis vs Fundamental Analysis
Buy
63
Prelude Therapeutics, Inc. (PRLD)
is a Buy
Is Prelude Therapeutics, Inc. a Buy or a Sell?
-
Prelude Therapeutics, Inc. stock is rated a BuyThe current Prelude Therapeutics, Inc. [PRLD] share price is $2.45. The Score for PRLD is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
Prelude Therapeutics, Inc. Stock Info
Market Cap:
154M
Price in USD:
2.45
Share Volume:
267.2K
Prelude Therapeutics, Inc. 52-Week Range
52-Week High:
4.22
52-Week Low:
0.61
Buy
63
Prelude Therapeutics, Inc. (PRLD)
is a Buy
Prelude Therapeutics, Inc. Share Price Forecast
-
What is the Prelude Therapeutics, Inc. stock price today?The Prelude Therapeutics, Inc. stock price is 2.45 USD today.
-
Will PRLD stock go up or go down?Prelude Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Prelude Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Prelude Therapeutics, Inc. is not overvalued.
Is Prelude Therapeutics, Inc. Stock a Buy?
-
Prelude Therapeutics, Inc. share price is 2.45 while PRLD 8-day exponential moving average is 1.85, which is a Buy signal.
-
The stock price of PRLD is 2.45 while Prelude Therapeutics, Inc. 20-day EMA is 1.11, which makes it a Buy.
-
Prelude Therapeutics, Inc. 50-day exponential moving average is 0.53 while PRLD share price is 2.45, making it a Buy technically.
-
PRLD stock price is 2.45 and Prelude Therapeutics, Inc. 200-day simple moving average is 0.15, creating a Buy signal.
Fundamental Analysis of Prelude Therapeutics, Inc.
Is Prelude Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.50 per share, and an increase next year of $0.13 per share.
Technical Analysis of Prelude Therapeutics, Inc.
Should I short Prelude Therapeutics, Inc. stock?
-
PRLD Moving Average Covergence Divergence (MACD) indicator is 0.62, suggesting Prelude Therapeutics, Inc. is a Buy
-
Prelude Therapeutics, Inc. Relative Strength Index (RSI) is 68.47, which suggest Prelude Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Prelude Therapeutics, Inc. is (1.46 - 2.06), which suggest Prelude Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Prelude Therapeutics, Inc. is (1.01 - 1.85), which suggest Prelude Therapeutics, Inc. is a Buy
* Prelude Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.